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of the/~-oxfdation pathway. To evaluate the diagnostic value of positron emis- 
sion tomography (PET) with FTHA in patients with coranaPj artery disease 
and reduced left ventricular function, 21 patients with mufliveasal disease 
and chronic myocardial infarction (EF 33 ± 8%) were studied. Myocardial 
perfusion ~ vipbll~y were assessed by Tc-99m sastamibl single photon 
emission computed tomography and by F-18 tiuoro-deoxyglucoss (FDG) 
PET imaging. 
The relationship between seetamibl defects and regional FDG and FTHA 
uptake was evaluated by computerized semtquantitatfve comparison for 33 
left ventdcular egions with normalization of tracer uptake to tho region with 
highest sastamibl uptake. Regional seetamibl and FTHA uptake showed a 
good correlation with r = 0.80, whereas asstamibl and FDG demonslmtod a
weak corralation (r = 0,55). Regions were categorized by the severity of the 
per[usion defect: group A (normal): ssetamibl uptake ~ normal - -  2 SD; B 
(mild defect): sestamibl < normal - -  2 SD; C (severe defect): soslam~i < 
0.5 (normal - -  2 SO). 
Group/uptake Sestamlbl (%) FTHA(%) FOG(%) 
A (~- 340) 85-1-9 87:1:15 86-1-17 
B(n- 183) 59=E6 G5±19 714-22 
C.(n- 190) 374-8 38:1:13 554-17' 
*p < 0.01 vs sestamll~ and vs FTHA 
In 85 regions of group C categorized as scar by concordant f~luction 
of sastamibl and FDG uptake, FTHA and FDG uptake was parallel < 50% 
in all regions. In 52 regions of group C with a significant mismatch be- 
tween perfusion (sestamibi 40 ± 6%) and glucose metabolism (FDG 87 ± 
13%) indicating ischemicalty compromized myocardium, FTHA uptake (44 
20%) was reduced < ,5(~o in 44/52 (85%) regions. These data suggest 
that regional FTHA uptake predominantly reflects myocardial pedusion and 
underestimates tissue viability in myocardium with markedly reduced blood 
flow. 
~ l n  Vlvo Scintillati'~n Imaging of  1311-Lsbelled 
c-Myc Antisenas Ol lgonucleotldas After Arterial 
Transfeetion 
R6ml Marlal, Angelica Fleser, Neff G, Hartman, Jean-Paul Soucy, 
Martin Bouchard, Pierre Voisine, Guy Leclerc. Notre-Dame Hospital, 
Montreal, Qu#bec, Cana:la 
In considering the use of antissnse (AS) otigonucleotides (ODN) for the 
prevention of restenosis, it is imperative to study (he bfodis~bution of the 
ODN after transfoction. The purpose of this study was to evaluate the in vivo 
fate of ODN transfected to the vessel wall using an tat I-labelled c-myc AS. 
To allow the labelling of the AS, an aminolinker was added to the 5' end of 
the ODN at the end of the synthesis. Isolated portions (1 cre) of denuded 
carotid artery of Now-Zealaed white rabbits were transfeeted for 2 h before 
blnod circulation was reestablished. The transfections were done using either 
radlolabelled ODN or radioactive sodium iodide (5.55 MBq 131 I). Imaging of 
the mbbfls was done with a gamma camera beth during the transfections 
and 5 rain., 30 rain., 1, 2, 3, 24, 48, and 72 h after reestablishing the blood 
cimuletion. In animals which received sodium iodide° it was etimineted from 
the denuded artery within the first hour, and accumulated mainly in the liver 
and the thyroid gland. Conversely, 26.3% of the amount of the labelled AS 
used for the transfection was detected at the transfection site 5 rain. after 
reestablishing blood circulation. This quantity decreased by 40% over tho 
next 3 h (16, 4, % of the odglnal 5.55 MBq) which then diminished gradually an 
additional 15% at 24 h as 11.9"/o f the initial input still remained within the 
denuded podion of the carolid. At that ime, 21.7% of the total dose remaining 
in the animal was located in the liver and no focal uptake of ODN was noticed 
in other organs. After 48 h, the presence of labelled AS at the transfectlon site 
was no longer evidont end radioactivity accumulation became increasingly 
visible in the thyroid gland. Conclusions: 1 w In vivo artedal penalration of 
the transfeuted ODN Is relatively limited and long term retention appaam to 
be restricted to the first 48 h post-transfoetion. 2 ~ The use of high energy 
radlonuclide to label AS molecules provides a useful tool to foflow the in vfvo 
distribution of tho transfected ODN. 
~ Metalodobenzylguanadlne (MIBG) Imaging or 
Heart Rate Variability for  Assessment of  Dialyt ic 
Cardiac Autonomic Dysfunct ion 
Michaal R. Freeman, David Newman, Paul Dorian, Anetoly i.anger. St. 
Michael's Hospital, Toronto, ON, Canada 
Autonomic dysfunction (AD) in diabetics confora a poor prognosis. 11~- 
MIBG offers a direct and quantitetive (QT) assessment of cardiac efferent 
sympathetic denervation while heart rate variability (HRV) reflects overall 
autonomic balance. We therefore studied the relationship between MIBG 
and HRV in 65 asymptomatic diabetic pla classified with and without AD 
based on 5 bedside m~n,,isvers (AD ff > 2 abnormal responses). HRV was 
derived from 48 hr Hcltar menitofing measured as the area undur the curve 
of the low frequency (0.04-0.15 I-Iz) ,'LF) and high frequency (0.15-0.40 Hz) 
(HF) band and alandard eviation (SD) of HR, while 112a-MIBG tomngraphic 
defect size, by comparison to a normal data base, was QT measured as % 
total myocardium >_ 2 standard eviation below normal and corrected for rest 
MIBI uptake. The results are shown in the table: 
LF HF SD MIBG (QT) 
NoAD(n= 19) 5.94-0.8 4.3 :b 0.8 464-11 4±6 
AD (n- 46) 5.14-1.0 4.0___1.1 37=~13 17±17 
p 0.01 0.23 0.02 0.0001 
MIBG (QT) correlated with LF (r = -0.39, p = 0.006), HF (r = -0.33, p 
< 0.02) and SD (r = -0.32, p < 0.03). LF correlated with HF (r = 0.86, 
p < 0.0001). MIBG was the only independent predictor of AD by multiple 
regression analysis. 
Thus, MIBG imaging and heart rate variability are related but MIBG uptake 
mere objectively and directly assesses cardiac sympathetic function. 
[ '~ '~ ' ]  HLgl-Technetlum-ggm: Kinetics of  a New 
Hypoxla Avid Imaging Agent in Normal and 
Ischemlc Myoeardlum as Assessed by Gamma 
Camera !tongas 
Gerald Johnson III, Kiem N. Nguyen, Zhonglin UU, Ping Gao. 
Barbara Edwards, Colin M. Archer, Adam C. King, Timothy L North, Robert 
D. Okada, William K. Warren. Med/cal Research Institute of the University of 
Oklahoma Health Sctenoes Center, Tulsa, OK; Amersham International p/c. 
Buckinghamshire, UK 
SsrnTc-HL91(4,9-diaza-3,3,1O,10-tetramethyldodecan-2,11-dione dioxim ) is 
a now hypoxia avid imaging agent which has been shown in preliminary 
studies to demenetrete increased uptake and retention in globally hypoxic 
myocardium in VitTO. The purpose of the current study was to determine 
whether these kinetics could be utilized to detect regional ischemia in vivo 
by gamma camera imaging. Fwe opan-chest dogs were studied. An 85-90% 
sustained reduction in flow was created by stenosls of the LCx. Injection 
of 5 mCi of ~mTc-HI.91 and microspheres was followed by gamma camera 
imaging over 240 minutes. Myocardial blood flow and tracer activity was 
determined by well counting. Heart slices were imagod ex vivo. Myocardial 
clearance was biphasic. Retention at 60 min for LCx was 31.9 ± 6,2% (mean 
:i. SEM), while LAD v~s 6.5 • 1.9%; p < 0.05. At 240 rain in vivo. LCx was 
36.7 ± 10.3%, while LAD was 5.9 4- 1.5%; p < 0.05. LCx/LAD activity ratio 
in vivo was 4.7 ± 1.2 at 240 min. LCx/LAD activity ratio (ex vivo) ranged 
horn 1,9:1 to 7.0:1 for short axis heart slices. The hypoxic/normoxic activity 
ratio was 4.5 ± 0.4 (n = 4). Blood activity was 13.8 4- 6.2% at 10 rain and 
2.5 ± 0.9% at 240 rain. Increased LCx aetMty was qualitatively appreciated 
on scans from each of the five expedrnents both in vivo and ex vivo. Images 
demonetrate increased ~Tc-HLgt retention in iscbemic myocardium. Thus, 
O~nTc-HL91 may be u~eful clinically in the positive delineation of low flow 
myocardial regions which are hypoxio. 
~ Detection of  MyoeardiM Ischemla With Dynamic 
SPECT 1-123-10dophenylpentadecsnoic Acid 
(IPPA) Imaging 
Edouard Oahar, Cindy Q.X. Shi, Eliot N. Hefler, Yi.Hwa L/u, Paul DeMan, 
Donald P. Oiona, Frans J. Th. Wackere, Albert J. Sinusas. Yale University, 
New Haven, CT 
We evaluated ynamic IPPA SPECT imaging in an open chest canine model 
of tow flow Ischemta s a potential method for detection of ischemin viable 
myocardtum. IPPA (4.0 mCi) was injected in 6 dogs in the presence of a 
sustained LAD alanosis, ischemla was confirmed by measures of mgionst 
oxygen consumption and lactate balance. Thickening fraction in dsk area 
(RA) was 5.4 :k 1.6%. There w-,,J no infarction by hlstocbemical staining. 
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52 rain. A subset of dogs (n - 4) had imeglng for 90 mln. Rediclabeled 
micmsphores were injected at the time of IPPA injection and before sacrifice. 
RA flow [% normal zone (Nl)] remained constant dudng the experiment 
(initial: 80 -~ 3,3%: late: 77 :b 3.3%, p ,, 0.58). Reconstructed SPECT short 
axis Images were quantified using circumferential count profiles and RA IPPA 
activity expressed as %NL Initial RA IPPA activity (7'9.4- 2.1%) was similar to 
the initial flow deficit (p = 0.78). However, at 52 rain after IPPA tnjeet;on the 
RA IPPA deficit had normalized (97 • 3.3%, n ,, 6) relative to initial RA IPPA 
activity (p ,, 0.01), and initial RA flow (p = 0.01). Myocardial IPPA clserenoe 
fTom RA and NI regions are shown for 4 dogs imaged for 90 min. Significant 
"normalization" of the defect occuned within 12 mtn post IPPA injection (p ,, 
0.03). 
Thus, measurement of myocardial IPPA clearance with dynamic SPEDT 
imaging can potentially ider~Ify ischemlc viable myoserdium accurately and 
as early as 12 min post injection. 
Nuclear Teatlng In Patients With High ~ n  
Llkelllzood of CAD or Previous MI: is There 
Benefit From Added Prognostic Value? 
Rory Hachamovltch, Daniel S. Barman, Hosen Kiat, ishao Cohen, J. 
Arthur C.,ablco, Amen Amanullah, John Friedman, George A, Diamond. 
Cedar~-Sinai Medica~ Center, Los Angeles, C~wiiomia 
"me enhanced stratification or benefit from added prognostic value of nuclear 
testing in patients with a high likelihood of CAD (hl'ah L~; Iz; no', known. Thus, 
we identified 2190 consecutive patients (pts) with high prescan Lk or previous 
MI who underwent rest TI/stress Tc-99m sestamibi dual isotope myocardial 
partus,'on SPEOT (DIMP$) and were followed for at least 1 year (yr} for 
events [cardiac death (CO), non.fatal myo~,ardial nfarctton(MI)]. DIMPS was 
visually assessed using 20 segments cored on a 5 point scale (0 = normal, 4 
= no uptake) and rest and stress scores were used to calculate the summed 
stress score (SSS), summed rest score ($R$), and summed ifference score 
(SDS = (SSS-SR$)). Results: During a moan foflow-up eriod of 1.8 :E 0.7 
years, 158 events occurred (91 M I and 67 CD), and 246 pts were censored for 
early revascu!arizatlan. Using a stepwIse Cox proportional hazards model, 
we found that pro-scan Lk and history ct CAD yielded significant inforrnation 
(x ~ = 12). SSS, the most predic6va nuclear variable, added significant further 
information (x = increased tO 56, p < 0.0001 ). Pts with normal scans had 0 .'P/= 
event rate in the first year (n = 425, 0,'P/, CD, 0% MI). Over this same time) 
period, pts with mffdly and severely abnormal scans were at similar isk for MI 
(11 = 471, 1048, 3.2%. 3.3% raspeetivaly). The dsk for CD was greater in pts 
with severely abnormal scans than mildly abnonnal scans (2.5% vs. 0.8%, 
p < 0.05). 898 of 1944 pts were reclassified by normal or mildly abnomlal 
scans as low dsk for CO by DIMPS. 
Conclusion: DIMP$ added significant incremental prognsalio value over 
clinical information alone in pts with high Lk of CAD or prior MI end reclassified 
46% of pts as low risk for cardiac death. 
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• Pulmonary Vascular Endothelial Function Is 
Depressed in Experimental Pulrnunary Embolism 
William L. Daisy, G.V.R,K. Sharma. West Roxbury VA Medical Center and 
Harvard Medical School, Boston, MA 
The role of endotheflum-dorlved relaxing factor (EDRF) In modulating pul- 
monary vascular reactivity was examined in experimental pulmonary em- 
bolism (PE) by Intrapatmonary infusions of asetyloholine (ACH) and n]tm- 
gly~rin (NTG). PE was orealed in 14 mongrel dogs by injecting autclogous 
thmmbin-cinfo into the jugular vein. Selective clna angiograms oi a segmental 
pulmonary artery (PA) were obtained after |nfualon of graded concantmtions 
j 9 ~1"1}1 t~fANOVA i'i 
of ACH (10 "e to 10 -s M) followed by NTG Into the PA before and after PE. 
Percent change in the PA diameter was measured using digital calipers. 
Dose response curves obtained from mean values for control and after each 
infusion of ACH are displayed. 
Reeutts: Infusion of ACH before PE (control) prodtced a dose dependent 
vasodifatstlon. Incontrast, AGH infusion after PE pnxlucod minimal change 
in PA diameter. (p ,, < 0.01 control vs. PE). However, infusion of NTG after 
PE produced pulmonary vesodllatatlon, indicating preserved endothallurn- 
independent vesodllalaflan. Conclusion: ACH mediated EDRF release from 
the pulmonary vascular endothellum is impaired in experimental polmonanl 
embolism. 
Effect o! Ollfedng Thromboplsstin Reagents end 
Lab instrumentation on INR I)etermleatlons for 
Patients Reealving Therapeutic Intensity 
Anticeagulant Therapy 
Nan K. Jasabson, Harvey S. Hahn, Lan T. Truong, Anita L McManus, 
David R. Ferry, Madlyn A. Johnston. Loma IJnda VAMC, Loma Llncte, CA; 
Hamiffon Civic Hospitals Research Center, Ontario, Canada 
Expanding indications for oral anticoagulant therapy have increased the need 
for reliable mon'~dng of astlcoagulant effect. The prothrombin time has 
been the standard test of anticoagulant intensity and is routinely reported 
as an International Normalized Ratio (INR) to compensate for differences In 
thmmboplasfln reagent sensitivities. To determine the expected varfation in 
INR determinations due to the different reagents and coagulation instruments 
utilized in clinical aboratories In North America, we prospectively collected 
serum samples fiom 50 unselectsd patients receiving wadadn therapy. For 
each patient sample, the INR was determined with each of 5 reagents 
(Intsmational Sensitivity Index (ISl) values ranging from 1.03 to 1.96) and 
on each of 3 instruments. The following table demonstrates the vadatlon 
in individual patient INR values obtained with diffsrent reagant/instmment 
cOmblnaflons at differing levels of anticoagulant intensity' demonstrating the 
increased variation due to instrumentation: 
Mean INR across Range of INR valueS Range of INR valueS 
reagents a~ reagents a..~oss Instruments 
2.5 2.1-3.1 1.9-8.3 
3.5 3,0-4.8 2.5--4.8 
4.5 3.8-3.2 3.2--5.4 
6,0 4.1-8.3 3.6-9.6 
Conclusion: Currently aveitebte commercial thmmboplastin reagents and 
coagulation ]nstn~ments allow for cliok:ally significant variation in INR deter- 
mtn~ttans across the spectrum of combinations available. This has significant 
implkT.atians both for the clinical management of patients and for the interpre- 
tation of research results. 
~ Thrombolytic Therapy Is • Premising Therapeutl© 
Option for Patients With Renal Arteriel Embolism 
Oiolflch C. Gufba, Raft Llechand, Miohaal Preus, Fdedrich tuft, 
Rainer Dlalz. Franz-Volhard Klinik, Humboldt Unh, ersity Beff/n, Germany 
Renal arterial embolism (RAE) is a rare, but severe manifestation of arterial 
embollc disease. With thrombolysls iT), if applied early, however, renal artsrj 
patsnoy may be restored and major abdominal surgnry and loss of renal 
function can be prevented. Currently, only 25 cases of RAE and T are 
reported In the I~reture. We report from 17 consecutive patients (IOLS) with 
anglographlcally proven RAE, who were treated with either rt-PA La. (n ,, 
12) (2 mg bolus and 1.5 mg/h for 12 h) or uroklnase I.a. (n = 5) (100.000 IU 
bolus and 100,000 IU/h for 12 h). Successful reperfuslon was achieved in 15 
tots (88%), Complete restoration of renal function however, as demonstrated 
by crealinlna ,znd szinttgraphio studies, was observed in only 6 pts (35%), 
paTllal impalrme,~t el renal fun~on In 8 pts (4"P/o) and complete loss of 
renal function in 3 (18%). Gross haen~turia occured in all 15 pts (100%) 
successfully repan'used. The incidence of major hasmorrhage was 12% (2 
pts). No fatal or cerebral h~.emorrhage was observed. It is of Importanse to 
mention, that after restoration of renal blood flow a period of 7 Io 10 days 
with severe renal dysfunction was a constant indinrj In all patients before the 
k~dnays finally recovered, Creatinino and BUN increased from pretreatl/teflt 
141 =t: 77 to a maximum value 612.4- 202 mmoBl on day 5 and 12,3 =1= 6,8 
to 40.8 -E 11.6 mmoVI respectively. They finally retomed ~ to 187 =t: 141 
mmol/I (Dreallnine) and 16.1 4* 9,3 mmol/I (BUN) on day 14, 
Conclusion: If diagnosis of RAE is set up in time and T is initiated early, 
reperfusion is possible in > 80%, reeulfing in good recovery of renal function 
in the majority of pts. T in RAE there/ore seems an effective therapeutic 
option with an acceptably low hasmorrhaglo risk. 
